Nakamoto Mika, Nakano Satoshi, Kawashima Shingo, Ihara Masafumi, Nishimura Yo, Shinde Akiyo, Kakizuka Akira
Laboratory of Functional Biology, Graduate School of Biostudies, Kyoto University, Yoshida Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan.
Arch Neurol. 2002 Mar;59(3):474-7. doi: 10.1001/archneur.59.3.474.
Oculopharyngeal muscular dystrophy (OPMD) is an adult-onset autosomal dominant muscle disease with a worldwide distribution. Recent findings reveal the genetic basis of this disease to be mutations in the polyA binding-protein 2 (PABP2) gene that involve short expansions of the GCG trinucleotide repeat encoding a polyalanine tract. The underlying mechanism causing the triplet-expansion mutation in PABP2 remains to be elucidated, although the DNA slippage model is thought to be a plausible explanation of that.
We analyzed PABP2 using polymerase chain reaction analysis and DNA sequencing in Japanese patients with pathologically confirmed OPMD, and found mutated (GCG)(6)GCA(GCG)(3)(GCA)(3)GCG and (GCG)(6)(GCA)(3)(GCG)(2)(GCA)(3)GCG alleles instead of the normal (GCG)(6)(GCA)(3)GCG allele. These mutated alleles could be explained by the insertions or duplications of (GCG)(3)GCA and (GCG)(2)(GCA)(3), respectively, but not by the simple expansion of GCG repeats. The clinical features of our patients were compatible with those of other Japanese patients carrying PABP2 that encodes a polyalanine tract of the same length, but were not compatible with those of Italian patients.
The mutated alleles identified in our Japanese patients with OPMD were most likely due to duplications of (GCG)(3)GCA and (GCG)(2)(GCA)(3) but not simple expansions of the GCG repeats. Therefore, unequal crossing-over of 2 PABP2 alleles, rather than DNA slippage, is probably the causative mechanism of OPMD mutations. All mutations that have been reported in patients with OPMD so far can be explained with the mechanism of unequal crossing-over. On the other hand, comparison of the clinical features of our patients with those of other patients in previous reports suggests that specific clinical features cannot be attributed to the length of the polyalanine tract per se.
眼咽型肌营养不良症(OPMD)是一种成年起病的常染色体显性遗传病,在全球范围内均有分布。最近的研究发现,该疾病的遗传基础是聚腺苷酸结合蛋白2(PABP2)基因发生突变,其中涉及编码多聚丙氨酸序列的GCG三核苷酸重复序列的短片段扩增。尽管DNA滑动模型被认为是对此现象的一种合理的解释,但导致PABP2中三核苷酸扩增突变的潜在机制仍有待阐明。
我们对经病理确诊的日本OPMD患者进行了聚合酶链反应分析和DNA测序,以分析PABP2基因,结果发现了突变的(GCG)6GCA(GCG)3(GCA)3GCG和(GCG)6(GCA)3(GCG)2(GCA)3GCG等位基因,而非正常的(GCG)6(GCA)3GCG等位基因。这些突变的等位基因可以分别用(GCG)3GCA和(GCG)2(GCA)3的插入或重复来解释,而不能用GCG重复序列的简单扩增来解释。我们患者的临床特征与其他携带相同长度多聚丙氨酸序列编码的PABP2的日本患者相符,但与意大利患者不符。
在我们的日本OPMD患者中鉴定出的突变等位基因很可能是由于(GCG)3GCA和(GCG)2(GCA)3的重复,而非GCG重复序列的简单扩增。因此,两个PABP2等位基因的不等交换,而非DNA滑动,可能是OPMD突变的致病机制。到目前为止,在OPMD患者中报道的所有突变都可以用不等交换机制来解释。另一方面,将我们患者的临床特征与先前报道中的其他患者进行比较表明,特定的临床特征不能仅归因于多聚丙氨酸序列的长度本身。